Evidence map›Paper›PMID 31120241›Full record

ArticleACS chemical biology2019

Omics Technologies to Understand Activation of a Biosynthetic Gene Cluster in Micromonospora sp. WMMB235: Deciphering Keyicin Biosynthesis.

Deepa Acharya, Ian Miller, Yusi Cui, Doug R Braun, Mark E Berres, Matthew J Styles, Lingjun Li, Jason Kwan, Scott R Rajski, Helen E Blackwell and 1 more

Abstract read
In one paragraph

Article in ACS chemical biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Microbiome composition modulates secondary metabolism in a multispecies bacterial community.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Deepa AcharyaPharmaceutical Sciences Division , University of Wisconsin-Madison , Madison , Wisconsin 53705 , United States.
Ian MillerPharmaceutical Sciences Division , University of Wisconsin-Madison , Madison , Wisconsin 53705 , United States.ORCID 0000-0001-5084-9035
Yusi CuiPharmaceutical Sciences Division , University of Wisconsin-Madison , Madison , Wisconsin 53705 , United States.
Doug R BraunPharmaceutical Sciences Division , University of Wisconsin-Madison , Madison , Wisconsin 53705 , United States.
Mark E BerresBioinformatics Resource Center , University of Wisconsin-Madison , Madison , Wisconsin 53706 , United States.
Matthew J StylesDepartment of Chemistry , University of Wisconsin-Madison , Madison , Wisconsin 53706 , United States.
Lingjun LiPharmaceutical Sciences Division , University of Wisconsin-Madison , Madison , Wisconsin 53705 , United States.ORCID 0000-0003-0056-3869
Jason KwanPharmaceutical Sciences Division , University of Wisconsin-Madison , Madison , Wisconsin 53705 , United States.
Scott R RajskiPharmaceutical Sciences Division , University of Wisconsin-Madison , Madison , Wisconsin 53705 , United States.
Helen E BlackwellDepartment of Chemistry , University of Wisconsin-Madison , Madison , Wisconsin 53706 , United States.ORCID 0000-0003-4261-8194
Tim S BugniPharmaceutical Sciences Division , University of Wisconsin-Madison , Madison , Wisconsin 53705 , United States.ORCID 0000-0002-4502-3084

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
Institutional Clinical and Translational Science AwardUL1TR000427 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2012 to 2016
$32.2M
BIOTECHNOLOGY TRAINING PROGRAMT32GM008349 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI FOX, BRIAN G · 1989 to 2019
$22.5M
Mass Spectrometric Studies of Neuropeptides in FeedingR01DK071801 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI LINGJUN LI · 2006 to 2026
$6.7M
Acquisition of a High-Field Dual Source FTICR-MS for Pharmaceutical ResearchS10RR029531 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI LI, LINGJUN · 2011 to 2011
$2.1M
Omics approaches for natural products discoveryR01GM104192 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BUGNI, TIMOTHY S · 2013 to 2019
$2.0M
Synthetic Ligands for Modulating Bacterial CommunicationR01GM109403 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI BLACKWELL, HELEN E. · 2014 to 2017
$1.2M
NCATS NIH HHS UL1 TR000427NCATS NIH HHS UL1 TR002373NCRR NIH HHS S10 RR029531NIDDK NIH HHS R01 DK071801NIGMS NIH HHS R01 GM104192NIGMS NIH HHS R01 GM109403NIGMS NIH HHS T32 GM008349
6 · The paper itself

Abstract

DNA sequencing of a large collection of bacterial genomes reveals a wealth of orphan biosynthetic gene clusters (BGCs) with no identifiable products. BGC silencing, for those orphan clusters that are truly silent, rather than those whose products have simply evaded detection and cluster correlation, is postulated to result from transcriptional inactivation of these clusters under standard laboratory conditions. Here, we employ a multi-omics approach to demonstrate how interspecies interactions modulate the keyicin producing kyc cluster at the transcriptome level in cocultures of kyc-bearing Micromonospora sp. and a Rhodococcus sp. We further correlate coculture dependent changes in keyicin production to changes in transcriptomic and proteomic profiles and show that these changes are attributable to small molecule signaling consistent with a quorum sensing pathway. In piecing together the various elements underlying keyicin production in coculture, this study highlights how omics technologies can expedite future efforts to understand and exploit silent BGCs.

Indexed as

GenomicsMetabolomicsMultigene FamilyProteomicsAnthracyclinesGenes, BacterialMicromonosporaOligosaccharidesQuorum SensingRhodococcusTranscriptomeAnthracyclineskeyicinOligosaccharides

Identifiers

PMID31120241
PMCPMC6591704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.